News from the FDA/CDC
News from the FDA/CDC
Teen vaping in the time of COVID-19
occurred...
News
FDA posts COVID vaccine guidance amid White House pushback
In the new guidance document, FDA officials outline what will be required for even a limited clearance, known as an emergency use authorization,...
News from the FDA/CDC
FDA OKs combination immunotherapy for first-line mesothelioma treatment
Combination nivolumab and ipilimumab has now been approved as first-line treatment in mesothelioma.
News from the FDA/CDC
Atezolizumab TNBC indication ‘in jeopardy’ because of phase 3 results
Negative results from the IMpassion131 trial may jeopardize the U.S. approval of atezolizumab in breast cancer.
News from the FDA/CDC
Pralsetinib: Second drug for RET+ NSCLC approved in U.S.
News from the FDA/CDC
FDA expands remdesivir use for all COVID-19 hospitalized patients
An EUA of remdesivir issued in May allowed the drug to be used only for patients with severe COVID-19, specifically, COVID-19 patients with low...
News from the FDA/CDC
FDA approves point-of-care COVID-19 antigen test
“This new COVID-19 antigen test is an important addition to available tests because the results can be read in minutes, right off the testing card...
News from the FDA/CDC
FDA approves clinical trials for cannabinoid drug designed to reduce COVID-19 lung inflammation
The drug going to clinical trials, ARDS-003, would “dampen the cytokine release” and prevent development of ARDS.
News
FDA updates hydrochlorothiazide label to include nonmelanoma skin cancer risk
Patients should continue taking the antihypertensive drug unless their doctor says otherwise, according to an FDA...
News from the FDA/CDC
FDA approves first liquid biopsy/NGS test for lung cancer
News
FDA approves belantamab in relapsed/refractory multiple myeloma
The first-in-class drug belantamab mafodotin (Blenrep) has been approved in the United States for use in relapsed and refractory multiple myeloma...